Replies to post #408939 on Amarin Corp Plc (AMRN)

[Whalatane]

N7. thx for your contributions to this board .
Unlike some who use it for endless personal attacks ...your posts are almost always informative and thus of value .
I'm jaded .
JT. We will out grow the generics ...nope ...at best AMRN will lower prices to match the generics in order to retain market share .
KM ..we have this Real World Data ...well in that case publish it instead of just talking about it .
Denner " haven't sold a single share " ...ok what ever ...so why are we trading at $1.23 .
If you liked it over $4 and loved it at an average $1.96 ...You must be over the moon now at $1.23 .
Who expects ANY of these guys " to be entirely honest " .
No offense but I don't

IMHO ...and you and others will disagree .
KM was in this for the salary , options and benefits . He was going to milk this as long as he could .
Denner is in this to at least get his money back and try and salvage his reputation

AMRN is now trading roughly for the value of its inventory and cash on hand. .
Anything that triggers the expectation of significantly more sales in the EU will likely lead to higher PPS .
For this who argue for a branded generic . Why bother . AMRN has told you they will lower prices to match or beat the generics to maintain their share of the US market .
For those who want a combo . KM told you its 3 yrs away at best . AMRN is in a cash conserve mode . They are unlikely to spend $ on that .
For this who want BP to ride to the rescue . Why would BP be interested until the EU market is more developed .

As I posted previously ...at these levels $1.23 ...AMRN becomes an interesting spec buy IF they can develop the EU market or IF ...see earlier post on the trial that shall not be named .

Good luck
Thx for your updates ...always worth reading

Kiwi

[hayward]

Number Sleven

I believe it was in one of his presentations ! How would that be possible ?

Michael